The EMA has published the second edition of the Product Lifecycle Management Insights Newsletter to help medicines developers to keep abreast of news and required actions related to the development of digital capabilities in the area of Product Lifecycle Management (PLM). In particular, the management of the authorisation and lifecycle of medicines, as well as medicinal product data.
Access the second PLM Insights Newsletter publication through this link.
How to subscribe:
Subscribe to the Product Lifecycle Management Insights.
What you will get:
PLM Insights provides you with:
· Quarterly updates in your inbox with the most important information and announcements;
· Reminders of actions and opportunities related to PLM tools and systems;
· Links through to more details and useful resources to support you in your preparation and adoption of new tools and systems.
About PLM:
Product Lifecycle Management (PLM) is one of three value streams in EMA’s Network Portfolio covering the digital capabilities to support the product lifecycle implemented by the Agency. PLM aims to digitally transform and optimise regulatory procedure management as well as data submission and reuse throughout the product lifecycle. The value stream works with EMA partners and stakeholders to deliver systems and services for the ultimate benefit of public and animal health in the EU.
PLM encompasses development of capabilities related to, among others, Product Management Service (PMS) data, Union product Database (UPD), electronic applications forms (eAF), electronic Product information (ePI), regulatory procedure management (RPM for IRIS).
